130 related articles for article (PubMed ID: 22687971)
1. [IDH1/2 gene mutations in myelodysplastic syndromes].
Yoshida K; Sanada M; Ogawa S
Rinsho Ketsueki; 2012 Apr; 53(4):391-5. PubMed ID: 22687971
[No Abstract] [Full Text] [Related]
2. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
Thol F; Weissinger EM; Krauter J; Wagner K; Damm F; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Ganser A; Heuser M
Haematologica; 2010 Oct; 95(10):1668-74. PubMed ID: 20494930
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic Syndrome and Sweet's Syndrome Are Associated with a Mutation in Isocitrate Dehydrogenase 1.
Snyder R; Libby T; Raciti P; Amin B; Jacobson M; Rakheja D; Fleming K; Bartenstein M; Zhu C; Goel S; Verma AK; Shastri A
Anticancer Res; 2018 Apr; 38(4):2201-2205. PubMed ID: 29599340
[TBL] [Abstract][Full Text] [Related]
4. IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes.
Wang N; Wang F; Shan N; Sui X; Xu H
Acta Haematol; 2017; 138(3):143-151. PubMed ID: 28873367
[TBL] [Abstract][Full Text] [Related]
5. A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.
Yoshida K; Sanada M; Kato M; Kawahata R; Matsubara A; Takita J; Shih LY; Mori H; Koeffler HP; Ogawa S
Leukemia; 2011 Jan; 25(1):184-6. PubMed ID: 20962861
[No Abstract] [Full Text] [Related]
6. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.
Kosmider O; Gelsi-Boyer V; Slama L; Dreyfus F; Beyne-Rauzy O; Quesnel B; Hunault-Berger M; Slama B; Vey N; Lacombe C; Solary E; Birnbaum D; Bernard OA; Fontenay M
Leukemia; 2010 May; 24(5):1094-6. PubMed ID: 20376084
[No Abstract] [Full Text] [Related]
7. IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression.
DiNardo CD; Jabbour E; Ravandi F; Takahashi K; Daver N; Routbort M; Patel KP; Brandt M; Pierce S; Kantarjian H; Garcia-Manero G
Leukemia; 2016 Apr; 30(4):980-4. PubMed ID: 26228814
[No Abstract] [Full Text] [Related]
8. Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
Lin TL; Nagata Y; Kao HW; Sanada M; Okuno Y; Huang CF; Liang DC; Kuo MC; Lai CL; Lee EH; Shih YS; Tanaka H; Shiraishi Y; Chiba K; Lin TH; Wu JH; Miyano S; Ogawa S; Shih LY
Haematologica; 2014 Jan; 99(1):28-36. PubMed ID: 23996483
[TBL] [Abstract][Full Text] [Related]
9. A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations.
Chou WC; Huang YN; Huang CF; Tseng MH; Tien HF
Blood; 2010 Jul; 116(3):495-6. PubMed ID: 20651083
[No Abstract] [Full Text] [Related]
10. Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.
Andrulis M; Capper D; Luft T; Hartmann C; Zentgraf H; von Deimling A
Leuk Res; 2010 Aug; 34(8):1091-3. PubMed ID: 20227112
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between clinical characteristics and myelodysplastic syndrome patients with isocitrate dehydrogenase gene mutations].
Tong HY; Hu C; Yu MX; Ma QL; Chen FF; Ye L; Wei JY; Xu GX; Mao LP; Li Y; Jin J
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3180-4. PubMed ID: 24405536
[TBL] [Abstract][Full Text] [Related]
12. IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).
Westman MK; Pedersen-Bjergaard J; Andersen MT; Andersen MK
Leukemia; 2013 Apr; 27(4):957-9. PubMed ID: 23192014
[No Abstract] [Full Text] [Related]
13. Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Platt MY; Fathi AT; Borger DR; Brunner AM; Hasserjian RP; Balaj L; Lum A; Yip S; Dias-Santagata D; Zheng Z; Le LP; Graubert TA; Iafrate AJ; Nardi V
J Mol Diagn; 2015 Nov; 17(6):661-8. PubMed ID: 26331834
[TBL] [Abstract][Full Text] [Related]
14. Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and
Alkhaldi H; Sewell D; Ning Y; Kallen ME; Emadi A; Hardy NM; Baer MR
Leuk Lymphoma; 2022 Dec; 63(12):3000-3003. PubMed ID: 35938721
[TBL] [Abstract][Full Text] [Related]
15. IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia.
Caramazza D; Lasho TL; Finke CM; Gangat N; Dingli D; Knudson RA; Siragusa S; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Leukemia; 2010 Dec; 24(12):2120-2. PubMed ID: 20861910
[No Abstract] [Full Text] [Related]
16. Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis.
Jin J; Hu C; Yu M; Chen F; Ye L; Yin X; Zhuang Z; Tong H
PLoS One; 2014; 9(6):e100206. PubMed ID: 24936872
[TBL] [Abstract][Full Text] [Related]
17. Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes.
Lin P; Luo Y; Zhu S; Maggio D; Yang H; Hu C; Wang J; Zhang H; Ren Y; Zhou X; Mei C; Ma L; Xu W; Ye L; Zhuang Z; Jin J; Tong H
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1037-1047. PubMed ID: 29549529
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms.
Molenaar RJ; Thota S; Nagata Y; Patel B; Clemente M; Przychodzen B; Hirsh C; Viny AD; Hosano N; Bleeker FE; Meggendorfer M; Alpermann T; Shiraishi Y; Chiba K; Tanaka H; van Noorden CJ; Radivoyevitch T; Carraway HE; Makishima H; Miyano S; Sekeres MA; Ogawa S; Haferlach T; Maciejewski JP
Leukemia; 2015 Nov; 29(11):2134-42. PubMed ID: 25836588
[TBL] [Abstract][Full Text] [Related]
19. Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.
Patnaik MM; Hanson CA; Hodnefield JM; Lasho TL; Finke CM; Knudson RA; Ketterling RP; Pardanani A; Tefferi A
Leukemia; 2012 Jan; 26(1):101-5. PubMed ID: 22033490
[TBL] [Abstract][Full Text] [Related]
20. The Molecular Pathology of Myelodysplastic Syndrome.
Haferlach T
Pathobiology; 2019; 86(1):24-29. PubMed ID: 29791902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
